Viewing StudyNCT00456833



Ignite Creation Date: 2024-05-05 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00456833
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-04-04

Brief Title: Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Non Small Cell Lung Cancer
Keywords:
Name View
erlotinib View
Non Small Cell Lung Cancer View
NSCLC View
Advanced lung cancer View
RAD View
RAD001 View